Clinical trials suggest tirzepatide may provide significant reductions in both HbA1c (a measure of long-term blood sugar control) and body weight
The peptide mimetic DPP-4 inhibitors including vildagliptin, saxagliptin and teneligliptin, were identified by peptide-based substrate substitution experiments, while the non-peptide mimetic group such as sitagliptin, alogliptin and linagliptin, were derived from the inhibitor and initially found in random screening
However, navigating the online landscape for semaglutide is fraught with potential pitfalls
Quick Answer: GLP-1 receptor agonists produce modest cholesterol reductions (LDL-C by 2-10%, triglycerides by 10-20%) but should complement, not replace, statin therapy for lipid management
Research has shown that amylin analogues like cagrilintide create a sense of fullness that persists longer than many other appetite-suppressing compounds
The only requirement is an assessment of renal function before initiating therapy, and periodical check-ups thereafter are recommended (Figure 3)